[go: up one dir, main page]

MXPA04006440A - Metodo para detectar arnm de papilomavirus humano. - Google Patents

Metodo para detectar arnm de papilomavirus humano.

Info

Publication number
MXPA04006440A
MXPA04006440A MXPA04006440A MXPA04006440A MXPA04006440A MX PA04006440 A MXPA04006440 A MX PA04006440A MX PA04006440 A MXPA04006440 A MX PA04006440A MX PA04006440 A MXPA04006440 A MX PA04006440A MX PA04006440 A MXPA04006440 A MX PA04006440A
Authority
MX
Mexico
Prior art keywords
mrna
detecting human
papillomarvirus
risk
expression
Prior art date
Application number
MXPA04006440A
Other languages
English (en)
Inventor
Karlsen Frank
Original Assignee
Norchip As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26246916&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04006440(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0200239A external-priority patent/GB0200239D0/en
Priority claimed from GB0214124A external-priority patent/GB0214124D0/en
Application filed by Norchip As filed Critical Norchip As
Publication of MXPA04006440A publication Critical patent/MXPA04006440A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se proporciona un metodo in vitro para tamizar mujeres para evaluar su riesgo de desarrollar carcinoma cervical, dicho metodo comprende el tamizado de la mujer para la expresion de transcripto de ARNm del gen E6 y opcionalmente del gen L1 de papilomavirus humano, en donde las mujeres positivas para la expresion de ARNm de L1 y/o E6 son calificadas como estando en riesgo de desarrollar carcinomas cervical. Se proporcionan tambien kits para llevar a cabo tales metodos.
MXPA04006440A 2002-01-07 2003-01-07 Metodo para detectar arnm de papilomavirus humano. MXPA04006440A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0200239A GB0200239D0 (en) 2002-01-07 2002-01-07 Method for detecting human papillomavirus mRNA
GB0214124A GB0214124D0 (en) 2002-06-19 2002-06-19 Method for detecting human papillomavirus mRNA
PCT/GB2003/000034 WO2003057914A2 (en) 2002-01-07 2003-01-07 METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA

Publications (1)

Publication Number Publication Date
MXPA04006440A true MXPA04006440A (es) 2005-03-31

Family

ID=26246916

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04006440A MXPA04006440A (es) 2002-01-07 2003-01-07 Metodo para detectar arnm de papilomavirus humano.

Country Status (20)

Country Link
US (4) US7553623B2 (es)
EP (5) EP2267155B2 (es)
JP (2) JP4558322B2 (es)
CN (1) CN100422342C (es)
AT (1) ATE354677T1 (es)
AU (2) AU2003201639C1 (es)
BR (1) BR0306723A (es)
CA (1) CA2472026A1 (es)
CY (1) CY1106621T1 (es)
DE (1) DE60311961T2 (es)
DK (2) DK2913407T3 (es)
EA (1) EA006975B1 (es)
ES (2) ES2282599T3 (es)
IL (2) IL162722A0 (es)
MX (1) MXPA04006440A (es)
NO (1) NO20042769L (es)
NZ (1) NZ533703A (es)
PT (1) PT1463839E (es)
SI (1) SI1463839T1 (es)
WO (1) WO2003057914A2 (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
US20110111389A1 (en) * 2001-11-07 2011-05-12 Diagcor Bioscience Incorporation Limited Rapid genotyping analysis for human papillomavirus and the device thereof
ES2282599T3 (es) 2002-01-07 2007-10-16 Norchip A/S Metodo para detectar arnm del virus del papiloma humano.
EP1369694A1 (en) * 2002-04-09 2003-12-10 MTM Laboratories AG Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
EP1507148B1 (en) * 2003-08-25 2005-02-23 MTM Laboratories AG Method for detecting carcinomas in a solubilized cervical body sample
WO2004081520A2 (en) * 2003-03-07 2004-09-23 The Public Health Research Institute Of The City Of New York, Inc. Optically decodable microcarriers, arrays and methods
US7361460B2 (en) * 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
EP1510820B1 (en) * 2003-08-25 2010-03-17 MTM Laboratories AG Method for detecting medically relevant conditions in a solubilized LBC sample
CA2539703C (en) 2003-09-25 2011-06-07 Third Wave Technologies, Inc. Detection of human papilloma virus (hpv) utilizing invasive cleavage structure assays
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
WO2005062940A2 (en) 2003-12-22 2005-07-14 John Wayne Cancer Institute Method and apparatus for in vivo collection and surveillance of circulating biological components
GB0404315D0 (en) * 2004-02-26 2004-03-31 Norchip As Improved detection of human papillomavirus
ITMO20040126A1 (it) 2004-05-21 2004-08-21 Bioanalisi Ct Sud S N C Di Per Sistema per la ricerca ed identificazione di agenti patogeni
AU2005333163B2 (en) 2004-11-09 2011-06-16 Gen-Probe Incorporated Compositions and methods for detecting Group A streptococci
AU2005314061B2 (en) 2004-12-08 2010-01-28 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
EP2460893B1 (en) 2005-06-20 2013-08-28 Advanced Cell Diagnostics, Inc. Multiplex detection of nucleic acids
ATE474066T1 (de) 2005-11-15 2010-07-15 Genoid Kft Verfahren zum nachweis von pathogenen mittels molecular beacons
EP2343385B1 (en) 2006-04-11 2014-05-21 Bio-Rad Innovations HPV detection and quantification by real-time multiplex amplification
US7833716B2 (en) * 2006-06-06 2010-11-16 Gen-Probe Incorporated Tagged oligonucleotides and their use in nucleic acid amplification methods
WO2008071998A2 (en) * 2006-12-15 2008-06-19 Oncomethylome Sciences Sa Diagnostic methods for diseases caused by a hpv infection comprising determining the methylation status of the hpv genome
CA2673017C (en) 2006-12-21 2015-08-04 Gen-Probe Incorporated Methods and compositions for nucleic acid amplification
US7838215B2 (en) * 2007-09-25 2010-11-23 Canvir, Inc. Advanced cervical cell screening methods
US9435001B2 (en) 2007-11-01 2016-09-06 Self-Screen B.V. Detection method for cervical HPVS
JP5299986B2 (ja) * 2007-11-01 2013-09-25 国立大学法人山口大学 核酸の定量方法
WO2009129505A2 (en) * 2008-04-17 2009-10-22 Qiagen Gaithersburg, Inc. Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
US9090948B2 (en) * 2008-09-30 2015-07-28 Abbott Molecular Inc. Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
CN102203293A (zh) 2008-10-27 2011-09-28 奇亚根盖瑟斯堡股份有限公司 快速结果杂交捕获测定和系统
EP2184368A1 (en) 2008-11-07 2010-05-12 DKFZ Deutsches Krebsforschungszentrum Diagnostic transcript and splice patterns of HPV16 in different cervical lesions
EP2425019B1 (en) * 2009-05-01 2014-03-19 QIAGEN Gaithersburg, Inc. A non-target amplification method for detection of rna splice-forms in a sample
JP5826752B2 (ja) * 2009-09-14 2015-12-02 キアジェン ゲイサーズバーグ インコーポレイテッド 細胞学用培地に固定された組織サンプルから核酸またはタンパク質を回収するための組成物および方法
AU2011203450B2 (en) * 2010-01-04 2016-01-07 Qiagen Gaithersburg, Inc. Methods, compositions, and kits for recovery of nucleic acids or proteins from fixed tissue samples
US9689047B2 (en) * 2010-01-29 2017-06-27 Qiagen Gaithersburg Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
WO2011094528A2 (en) 2010-01-29 2011-08-04 Qiagen Gaithersburg, Inc. Method of determining and confirming the presence of an hpv in a sample
US20110275698A1 (en) * 2010-05-10 2011-11-10 Norchip A/S "test and treat" strategy for treating transforming hpv infection
EP2572001A2 (en) 2010-05-19 2013-03-27 QIAGEN Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
WO2011149897A1 (en) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes
EP3034625B1 (en) 2010-10-21 2017-10-04 Advanced Cell Diagnostics, Inc. An ultra sensitive method for in situ detection of nucleic acids
EP2661508B1 (en) * 2011-01-07 2018-09-12 QIAGEN Gaithersburg, Inc. Method for genotyping and quantifying a high-risk human papillomavirus
CN103476948A (zh) * 2011-01-28 2013-12-25 领先细胞医疗诊断有限公司 用于测定头颈癌和宫颈病变中的hpv状态的rnascope* hpv测定法
US9885092B2 (en) 2011-02-24 2018-02-06 Qiagen Gaithersburg Inc. Materials and methods for detection of HPV nucleic acids
US20130095474A1 (en) * 2011-10-13 2013-04-18 Joseph Mamone Design of stem-loop probes and utilization in snp genotyping
CA2854165C (en) 2011-11-03 2022-11-22 Qiagen Gaithersburg, Inc. Materials and method for immobilizing, isolating, and concentrating cells using carboxylated surfaces
CN102864224A (zh) * 2012-09-11 2013-01-09 南京大学 一种血清microRNAs试剂盒及其应用
GB201310933D0 (en) 2013-06-19 2013-07-31 Norchip As A method of cervical screening
US10072302B2 (en) * 2013-12-05 2018-09-11 Optipharm.Co., Ltd. Cervical cancer diagnosing method and diagnostic kit for same
WO2016005789A1 (en) * 2014-07-07 2016-01-14 Institut Pasteur Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus- associated cancer stages
CN106048014B (zh) * 2016-06-07 2019-12-10 博奥生物集团有限公司 一种用于实时检测nasba产物的高特异探针
US20190112673A1 (en) * 2017-05-10 2019-04-18 Genomic Vision Association between integration of high-risk hpv genomes detected by molecular combing and the severity and/or clinical outcome of cervical lesions
JP6831772B2 (ja) 2017-12-22 2021-02-17 株式会社Ｓｕｂａｒｕ 画像投影装置
CN114214343A (zh) * 2021-11-15 2022-03-22 上海市东方医院（同济大学附属东方医院） 一组高危型HPV整合所致的宫颈癌中特异表达的mRNA序列

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930007580B1 (ko) 1986-03-21 1993-08-13 엥스띠뛰 빠스뙤르 유두종 비루스 게놈으로부터 유도된 결정 dna 서열, 그의 시험관내 진단 목적용 용도 및 항원 조성물의 제조 방법
WO1988006634A1 (en) * 1987-02-26 1988-09-07 The University Of Sydney A method of detection of carcinogenic human papillomavirus
US5182377A (en) 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
DE3838269A1 (de) * 1988-11-11 1990-05-17 Behringwerke Ag Nachweis humaner papillomavirus dna und ihrer expression in zervix-abstrichen
NL8900725A (nl) 1989-03-23 1990-10-16 Az Univ Amsterdam Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur.
US5234809A (en) 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
JP2791685B2 (ja) 1989-06-08 1998-08-27 寳酒造株式会社 パピローマウイルスの検出方法
EP0502994B1 (en) * 1989-12-01 1995-09-06 Amoco Corporation Detection of hpv transcripts
US5580970A (en) * 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
NL9000134A (nl) 1990-01-19 1991-08-16 Stichting Res Fonds Pathologie Primers en werkwijze voor het detecteren van humaan papilloma virus genotypen m.b.v. pcr.
US6582908B2 (en) 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5506105A (en) 1991-12-10 1996-04-09 Dade International Inc. In situ assay of amplified intracellular mRNA targets
JPH07508891A (ja) * 1993-05-06 1995-10-05 デイド、インターナショナル、インコーポレイテッド ヒト乳頭種ウイルス検出アッセイ
US6174668B1 (en) 1993-05-14 2001-01-16 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more target DNA's using primers having matched melting temperatures
EP2423322A1 (en) 1993-11-12 2012-02-29 PHRI Properties, Inc. Hybridization probes for nucleic acid detection, universal stems, methods and kits
DE4431174A1 (de) * 1994-09-01 1996-03-07 Deutsches Krebsforsch Nachweisverfahren für tumorspezifische mRNA
DE19506561C1 (de) 1995-02-24 1996-10-10 Deutsches Krebsforsch Verfahren zur Früherkennung von HPV-assoziierten Karzinomen bzw. von hochgradigen, durch HPV-verursachten Dysplasien
CA2237891C (en) 1995-11-15 2013-07-30 Gen-Probe Incorporated Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
US6027981A (en) 1997-10-27 2000-02-22 Texas Instruments - Acer Incorporated Method for forming a DRAM cell with a fork-shaped capacitor
JP2002508190A (ja) 1997-12-12 2002-03-19 ダイジーン・コーポレーション 万能収集媒質
AU4515699A (en) 1998-06-26 2000-01-17 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
WO2001073135A2 (en) * 2000-03-28 2001-10-04 Biosearch International Pty. Ltd. Approaches for hpv detection and staging by targeting the e6 gene region of the viral genome
US7439016B1 (en) 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
GB0018050D0 (en) * 2000-07-21 2000-09-13 Norchip As Detection of human papillomavirus mRNA
ATE348192T1 (de) * 2001-08-23 2007-01-15 Merck & Co Inc Multiplex-hpv-pcr-fluoreszenzassays unter verwendung mehrerer fluorophore
GB0200258D0 (en) 2002-01-07 2002-02-20 Norchip As Detection of human papillomavirus
ES2282599T3 (es) 2002-01-07 2007-10-16 Norchip A/S Metodo para detectar arnm del virus del papiloma humano.
GB0404315D0 (en) 2004-02-26 2004-03-31 Norchip As Improved detection of human papillomavirus

Also Published As

Publication number Publication date
CA2472026A1 (en) 2003-07-17
AU2003201639B2 (en) 2008-05-15
EP2267155B2 (en) 2016-09-07
JP2005514038A (ja) 2005-05-19
EP2272988A3 (en) 2011-06-15
EP2913407B1 (en) 2017-11-01
EA006975B1 (ru) 2006-06-30
AU2003201639C1 (en) 2009-02-26
US20130309658A1 (en) 2013-11-21
CY1106621T1 (el) 2012-01-25
JP4558322B2 (ja) 2010-10-06
JP5204132B2 (ja) 2013-06-05
BR0306723A (pt) 2004-12-21
EP1715062B1 (en) 2015-03-11
EP2267155B1 (en) 2013-03-13
US8420314B2 (en) 2013-04-16
HK1065827A1 (en) 2005-03-04
EP1715062A3 (en) 2007-07-11
US20050118568A1 (en) 2005-06-02
NZ533703A (en) 2006-05-26
EP2913407A1 (en) 2015-09-02
EP2272988A2 (en) 2011-01-12
JP2010131020A (ja) 2010-06-17
EP1715062A2 (en) 2006-10-25
AU2003201639A1 (en) 2003-07-24
EA200400919A1 (ru) 2005-02-24
NO20042769L (no) 2004-10-04
EP1463839B1 (en) 2007-02-21
WO2003057914A2 (en) 2003-07-17
US7553623B2 (en) 2009-06-30
EP2267155A2 (en) 2010-12-29
US7812144B2 (en) 2010-10-12
IL162722A (en) 2013-09-30
CN1639357A (zh) 2005-07-13
IL162722A0 (en) 2005-11-20
US20090253124A1 (en) 2009-10-08
AU2008205436A1 (en) 2008-09-04
DE60311961T2 (de) 2007-10-18
SI1463839T1 (sl) 2007-08-31
ES2654909T3 (es) 2018-02-15
PT1463839E (pt) 2007-05-31
EP2267155A3 (en) 2011-06-08
WO2003057914A3 (en) 2004-02-26
DE60311961D1 (de) 2007-04-05
CN100422342C (zh) 2008-10-01
ATE354677T1 (de) 2007-03-15
US20090275044A1 (en) 2009-11-05
DK2913407T3 (en) 2018-01-15
DK1463839T3 (da) 2007-07-02
EP1463839A2 (en) 2004-10-06
ES2282599T3 (es) 2007-10-16

Similar Documents

Publication Publication Date Title
MXPA04006440A (es) Metodo para detectar arnm de papilomavirus humano.
Kumar et al. Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications
WO2004065583A3 (en) Gene expression markers for breast cancer prognosis
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
PL372107A1 (en) Over-expression of extremozyme genes in pseudomonads and closely related bacteria
WO2005020785A3 (en) Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
SG179410A1 (en) Therapeutic uses of inhibitors of rtp801
AU2003299864A1 (en) Sirna compounds and methods for the downregulation of gene expression
WO2005117938A3 (en) Methods of treating ocular conditions
UA101814C2 (ru) Фактор, задействованный в латентной инфекции герпесвирусом, и его применение
AU2003302732A1 (en) Method for identifying risk of breast cancer and treatments thereof
MX2007002508A (es) Cepas que producen ferulato esterasa y metodos para usarlas.
SG149699A1 (en) Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
AU2003300324A8 (en) Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
WO2005113831A3 (en) Biomarkers for multiple sclerosis and methods of use thereof
WO2001004343A3 (en) A method for determining the prognosis of cancer patients by measuring levels of bag expression
AU2003201992A1 (en) Detection of human papillomavirus e6 mrna
GB0227274D0 (en) Probes
DE602006009117D1 (de) Verfahren zur identifizierung von die stresstoleranz in hefe erhöhenden genen sowie verwendung dieser gene zur verbesserung von hefestämmen
PT1594879E (pt) Processo e intermediários para a preparação de olanzapina
Chen et al. Increased alternative macrophage-2 (M2) polarization with Trib1 gene over expression in myeloma patients with progressive disease and Jak2 inhibitors reduce M2 polarization
WO2005032350A3 (en) Determinationof phenotype of cancer and of precancerous tissue
AU2003295246A1 (en) In vitro diagnosis method for early detection of cervical dysplasias and cancer, associated with hpv
UA40925A (uk) Спосіб бактеріотерапії хворих на бронхіальну астму з врахуванням циркадіанних хроноритмів мікрофлори порожнини товстої кишки

Legal Events

Date Code Title Description
FG Grant or registration